0

Cancer Cachexia Therapeutics Market by Product and Geography - Forecast and Analysis 2019-2023

  • Published: Oct 2019
  • Pages: 148
  • SKU: IRTNTR40028
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The global cancer cachexia therapeutics market has the potential to grow by USD 568.85 million during 2019-2023, and the market's growth momentum will accelerate throughout the forecast period.

This report provides a detailed analysis of the market by geography (Asia, Europe, North America, and ROW), and product (progestogens, corticosteroids, combination therapies, and other therapeutics). Also, the report analyzes the market's competitive landscape and offers information on several market vendors, including AbbVie Inc., ANI Pharmaceuticals Inc., Bristol-Myers Squibb Co., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals Plc., Merck & Co. Inc., Mylan NV, Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.

Market Overview

Cancer-Cachexia-Therapeutics-Market-Overview

Browse TOC and LoE with selected illustrations and example pages of cancer cachexia therapeutics market

Request a FREE sample now!

Market Competitive Analysis

The market is fragmented, and the degree of fragmentation will increase during the forecast period. Vendors are focusing on developing novel therapies for the treatment of cancer cachexia, and on expanding their market reach, established vendors are adopting R&D strategies. AbbVie Inc., ANI Pharmaceuticals Inc., Merck & Co. Inc., and Pfizer Inc. are some of the major market participants. Though the accelerating growth momentum will offer immense growth opportunities, the lack of approved therapies to treat cancer cachexia will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market position, this cancer cachexia therapeutics market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market's competitive landscape and provides information on the products offered by various companies. Moreover, this cancer cachexia therapeutics market analysis report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading cancer cachexia therapeutics companies, including:

  • AbbVie Inc.
  • ANI Pharmaceuticals Inc.
  • Bristol-Myers Squibb Co.
  • Fresenius SE & Co. KGaA
  • Hikma Pharmaceuticals Plc.
  • Merck & Co., Inc.
  • Mylan NV
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

Cancer Cachexia Therapeutics Market: Segmentation by Region

Cancer-Cachexia-Therapeutics-Market-Share-by-Region

For more insights on the cancer cachexia therapeutics market share of various regions Request for a FREE sample now!

The increasing number of cancer patients in North America is directly proportional to the number of people with cancer cachexia, and this data indicates promising market opportunities in the region. The high healthcare expenditure in the region is driving the growth of the cancer cachexia therapeutics market.

About 44% of the market's growth will originate from North America during the forecast period. The region is witnessing a high prevalence of cancer and the need for approved drugs, which is inducing several companies to invest in this region. This will subsequently drive the demand for cancer cachexia therapeutics, propelling cancer cachexia therapeutics market growth. The US is the critical market for cancer cachexia therapeutics in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.

Cancer Cachexia Therapeutics Market: Segmentation by Product

Cancer-Cachexia-Therapeutics-Market-Share-by-Product

Request for a FREE sample and Get more information on the market contribution of various product segments

The most effective and safest option for the palliative treatment of cancer cachexia are progestogens. Progestogens facilitate weight gain and improve appetite thereby improving the quality of patients with cancer cachexia. This will increase the adoption of progestogens.

However, market growth in this segment will be slower than the growth of the market in the combination therapies segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the cancer cachexia therapeutics market size.

Cancer Cachexia Therapeutics Market: Key Drivers and Trends

The high prevalence of cancer cachexia provides significant opportunities for market vendors. The large patient cohort requires multiple physician visits and numerous medications for the treatment of cancer cachexia. Asia has a vast cancer patient population, with China, India, and Japan being among the top five countries with the highest incidence of cancer. The high prevalence of cancer cachexia will subsequently drive cancer cachexia therapeutics market growth over the forecast period.

  • The rising preference for novel therapies is a significant trend that will affect the cancer cachexia therapeutics market landscape.
  • Currently, there are no approved drugs available for the treatment of cancer cachexia.
  • The combination of multiple medical and nutritional therapeutic interventions for the treatment of cachexia is gaining traction among patients as well as oncology physicians.
  • The increasing R&D by companies and the availability of novel drugs for the treatment of cancer cachexia facilitates their adoption among patients.
  • These factors are leading to the rising preference for novel therapies, which is one of the critical cancer cachexia therapeutics market trends that will influence market growth.
  • During 2019-2023, the market will grow at a CAGR of almost 6%.

Cancer-Cachexia-Therapeutics-Market-Report

Request for a FREE sample now!

Cancer Cachexia Therapeutics Market: Key Highlights of the Report for the Forecast Period 2019-2023

  • CAGR of the market during the forecast period 2019-2023
  • Detailed information on factors that will accelerate the growth of the cancer cachexia therapeutics market during the next five years
  • Precise estimation of the global cancer cachexia therapeutics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the cancer cachexia therapeutics industry across Asia, Europe, North America, and ROW
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of cancer cachexia therapeutics companies  

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Progestogens - Market size and forecast 2018-2023
  • Corticosteroids - Market size and forecast 2018-2023
  • Combination therapies - Market size and forecast 2018-2023
  • Other therapeutics - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Growing awareness about supportive care for cancer patients
  • Increasing healthcare expenditure
  • Rising preference for novel therapies

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AbbVie Inc.
  • ANI Pharmaceuticals Inc.
  • Bristol-Myers Squibb Co.
  • Fresenius SE & Co. KGaA
  • Hikma Pharmaceuticals Plc
  • Merck & Co. Inc.
  • Mylan NV
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Reports 2019
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>